Dimensional Fund Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.43M Buy
210,313
+20,099
+11% +$186K ﹤0.01% 2774
2026
Q2
$1.78M Buy
190,214
+53,612
+39% +$508K ﹤0.01% 2762
2026
Q1
$1.28M Buy
136,602
+59,248
+77% +$499K ﹤0.01% 2794
2025
Q4
$630K Buy
+77,354
New +$955K ﹤0.01% 2934
2025
Q1
– Sell
-16,075
Closed -$190K – 3334
2024
Q4
$190K Hold
16,075
– – ﹤0.01% 3171
2024
Q3
$332K Hold
16,075
– – ﹤0.01% 3096
2024
Q2
$727K Hold
16,075
– – ﹤0.01% 2962
2024
Q1
$631K Sell
16,075
-617
-4% -$15.2K ﹤0.01% 3001
2023
Q4
$101K Sell
16,692
-12,531
-43% -$67.3K ﹤0.01% 3278
2023
Q3
$197K Sell
29,223
-2,377
-8% -$16.5K ﹤0.01% 3222
2023
Q2
$248K Buy
31,600
+17,919
+131% +$161K ﹤0.01% 3200
2023
Q1
$99.5K Buy
+13,681
New +$59.9K ﹤0.01% 3301
2022
Q1
– Sell
-1,052
Closed -$19K – 3522
2021
Q4
$19K Hold
1,052
– – ﹤0.01% 3530
2021
Q3
$32K Sell
1,052
-1,141
-52% -$45K ﹤0.01% 3489
2021
Q2
$120K Buy
+2,193
New +$122K ﹤0.01% 3394

Other funds holding CRBP

Dimensional Fund Advisors's CRBP Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Corbus Pharmaceuticals (CRBP) stake by 11% in Q3 2026, buying an estimated $186K and bringing the position to 210,313 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Dimensional Fund Advisors first reported a position in CRBP in Q2 2021 and has held it in 15 quarters since. The position peaked at $1.78M in Q2 2026. 120 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • Dimensional Fund Advisors held 210,313 shares of Corbus Pharmaceuticals worth $1.43M as of Q3 2026.
  • Dimensional Fund Advisors bought 20,099 Corbus Pharmaceuticals shares in Q3 2026, an estimated $186K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2774 holding.
  • Dimensional Fund Advisors first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's Corbus Pharmaceuticals position peaked at $1.78M in Q2 2026.
  • 120 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.